OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising.
A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising. Though R&D complexity has grown more than 50% since 2008, resources dedicated to pediatric studies have increased across most R&D functions.
Read the full release here